HomeNKTR • NASDAQ
add
Nektar Therapeutics
Previous close
$1.27
Day range
$1.23 - $1.32
Year range
$0.41 - $1.93
Market cap
239.30M USD
Avg Volume
821.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 23.49M | 14.59% |
Operating expense | 50.23M | 5.64% |
Net income | -52.36M | -2.43% |
Net profit margin | -222.93 | 10.61% |
Earnings per share | -0.19 | 30.70% |
EBITDA | -35.03M | -9.87% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 271.24M | -33.75% |
Total assets | 343.33M | -30.54% |
Total liabilities | 263.65M | -11.33% |
Total equity | 79.69M | — |
Shares outstanding | 184.08M | — |
Price to book | 2.95 | — |
Return on assets | -24.67% | — |
Return on capital | -27.73% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -52.36M | -2.43% |
Cash from operations | -37.70M | 26.82% |
Cash from investing | 16.98M | -32.53% |
Cash from financing | 19.00K | 5.56% |
Net change in cash | -20.70M | 21.07% |
Free cash flow | -10.54M | 50.79% |
About
Founded
1990
Headquarters
Website
Employees
137